tirzepatide fda shortage list Clarifies Compounding Rules as Supply Stabilizes tirzepatide fda decision fda shortage

Monitoring and reporting side effects are critical to managing your health on semaglutide

Compound that with the enamel erosion that can come from vomiting, gastroesophageal reflux disease (GERD), or acid reflux (all of which can be caused by a GLP-1), and your mouth is more likely to experience things like cavities, tooth sensitivity, gingival inflammation, and taste disturbances

Weight loss injections like semaglutide serve as a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking the hormone released in the gut in response to eating

In July 2025, the Novo Collaboration Agreement became effective and, subsequently, we received a one-time, non-refundable upfront payment of $195.0 million, which was recorded as deferred revenue in our balance sheet

Its currently being studied in a phase 2 trial to test different doses

Clin Cancer Res 2021 Apr 8 [Epub]